Chemotherapy and radiation therapy in the treatment of squamous cell carcinoma of the vulva: Are two therapies better than one?

Gynecologic Oncology

Volumn 113, Issue 3, 2009, Pages 379-383

  Moore, David H ^a  

^a Gynecologic Oncology of Indiana   (United States)

Author keywords

Chemotherapy; Radiation; Vulva cancer

Indexed keywords

BLEOMYCIN; CISPLATIN; FLUOROURACIL; MITOMYCIN C;

CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; HUMAN; PRIORITY JOURNAL; RADIATION DOSE; REVIEW; SQUAMOUS CELL CARCINOMA; VULVA CARCINOMA; VULVECTOMY;

CARCINOMA, SQUAMOUS CELL; COMBINED MODALITY THERAPY; FEMALE; HUMANS; VULVAR NEOPLASMS;

EID: 67349196487     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.01.004     Document Type: Review

References (77)

1. American Cancer Society. Cancer facts and figures 2008 (2008), American Cancer Society, Atlanta
2. Stroup A.M., Harlan L.C., and Trimble E.L. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol. Oncol. 108 (2008) 577-583
3. Taussig F.J. Cancer of the vulva. Am. J. Obstet. Gynecol. 40 (1940) 764
4. Way S. The anatomy of the lymphatic drainage of the vulva and its influence on the radical operation for carcinoma. Ann. Coll. Surg. Eng. 3 (1948) 187
5. Hacker N.F., Leuchter R.S., Berek J.S., et al. Radical vulvectomy and bilateral inguinal lymphadenectomy through separate groin incisions. Obstet. Gynecol. 58 (1981) 574
6. DiSaia P.J., Creasman W.T., and Rich W.M. An alternative approach to early cancer of the vulva. Am. J. Obstet. Gynecol. 133 (1979) 825
7. Hacker N.F., Berek J.S., Lagasse L.D., et al. Individualization of treatment for stage I squamous cell vulvar carcinoma. Obstet. Gynecol. 63 (1984) 155
8. Hoffman M.S., Gunesakaran S., Arango H., DeCesare S., Fiorica J.V., Parsons M., and Cavanagh D. Lateral microscopic extension of squamous cell carcinoma of the vulva. Gynecol. Oncol. 73 (1999) 72-75
9. Chan J.K., Sugiyama V., Pham H., Gu M., Rutgers J., Osann K., Cheung M.K., Berman M.L., and DiSaia P.J. Margin distance and other clinico-pathologic prognostic factors in vulvar carcinoma: a multivariate analysis. Gynecol. Oncol. 104 (2007) 636-641
10. Sedlis A., Homesley H., Bundy B.N., et al. Positive groin nodes in superficial squamous cell vulvar carcinoma. Am. J. Obstet. Gynecol. 156 (1987) 1159-1164
11. Wilkinson E.J., Rico M.J., and Pierson K.K. Microinvasive carcinoma of the vulva. Int. J. Gynecol. Pathol. 1 (1982) 29
12. Oonk M.H., Hollema H., de Hullu J.A., and van der Zee A.G. Prediction of lymph node metastases in vulvar cancer: a review. Int. J. Gynecol. Cancer 16 (2006) 963-971
13. Homesley H.D., Bundy B.N., Sedlis A., Yordan E., Berek J.S., Jahshan A., and Mortel R. Prognostic factors for groin node metastasis in squamous cell carcinoma of the vulva (A Gynecologic Oncology Group Study). Gynecol. Oncol. 49 (1993) 279-283
14. Morris J.M. A formula for selective lymphadenectomy. Obstet. Gynecol. 50 (1977) 152
15. Stehman F.B., Bundy B.N., Dvoretsky P.M., and Creasman T. Early Stage I carcinoma of the vulva treated with ipsilateral superficial inguinal lymphadenectomy and modified radical hemivulvectomy: a prospective study of the Gynecologic Oncology Group. Obstet. Gynecol. 79 (1992) 490
16. Berman M.L., Soper J.T., Creasman W.T., et al. Conservative surgical management of superficially invasive Stage I vulvar carcinoma. Gynecol. Oncol. 35 (1989) 352
17. Burke T.W., Levenback C., Coleman R.C., et al. Surgical therapy of T1 and T2 vulvar carcinoma: further experience with radical wide excision and selective inguinal lymphadenectomy. Gynecol. Oncol. 57 (1995) 215
18. Gordinier M.E., Malpica A., Burke T.W., Bodurka D.C., Wolf J.K., Jhingran A., Ramirez P.T., and Levenback C. Groin recurrence in patients with vulvar cancer with negative nodes on superficial inguinal lymphadenectomy. Gynecol. Oncol. 90 (2003) 625-628
19. Levenback C., Burke T.W., Gershenson D.M., et al. Intraoperative lymphatic mapping for vulvar cancer. Obstet. Gynecol. 84 (1994) 163
20. Barton D.P.J., Berman C., Cavanagh D., et al. Lymphoscintigraphy in vulvar cancer: a pilot study. Gynecol. Oncol. 46 (1992) 341
21. DeCesare S.L., Fiorica J.V., Roberts W.S., et al. A pilot study utilizing intraoperative lymphoscintigraphy for identification of the sentinel lymph nodes in vulvar cancer. Gynecol. Oncol. 66 (1997) 425
22. Van der Zee A.G.J., Oonk M.H., De Hullu J.A., et al. Sentinel node dissection is safe in the treatment of early-stage vulvar cancer. J. Clin. Oncol. 26 (2008) 884-889
23. Perez C.A., Grigsby P.W., Galakatos A., Swanson R., Camel H.M., Kao M.S., and Lockett M.A. Radiation therapy in management of carcinoma of the vulva with emphasis on conservation therapy. Cancer 71 (1993) 8707-8716
24. Homesley H.D., Bundy B.N., Sedlis A., and Adcock L. Radiation therapy versus pelvic node resection for carcinoma of the vulva with positive groin nodes. Obstet. Gynecol. 68 (1986) 733
25. Jackson K.S., Fankam E.F., Das N., et al. Unilateral groin and pelvic irradiation for unilaterally node-positive women with vulval carcinoma. Int. J. Gynecol. Cancer 16 (2006) 283-287
26. Podratz K.C., Symmonds R.E., and Taylor W.F. Carcinoma of the vulva: analysis of treatment failures. Am. J. Obstet. Gynecol. 143 (1982) 340
27. Boyce J., Fruchter R.G., Kasambilides E., et al. Prognostic factors in carcinoma of the vulva. Gynecol. Oncol. 20 (1985) 364
28. Binder S.W., Huang I., Fu Y.S., et al. Risk factors for the development of lymph node metastasis in vulvar squamous carcinoma. Gynecol. Oncol. 37 (1990) 9
29. Heaps J.M., Fu Y.S., Montz F.J., et al. Surgical-pathologic variables predictive of local recurrence in squamous cell carcinoma of the vulva. Gynecol. Oncol. 38 (1990) 309
30. Faul C.M., Mirmow D., Huang Q., Gerszten K., Day R., and Jones M.W. Adjuvant radiation for vulvar carcinoma: improved local control. Int. J. Radiat. Oncol. Biol. Phys. 38 (1997) 381
31. Busch M., Wagener B., Schaffer M., and Duhmke E. Long-term impact of postoperative radiotherapy in carcinoma of the vulva FIGO I/II. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 213-218
32. Stehman F., Bundy B., Thomas G., et al. Groin dissection versus groin radiation in carcinoma of the vulva: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 24 (1992) 39
33. Koh W.J., Chiu M., Stelzer K.J., et al. Femoral vessel depth and the implications for groin node radiation. Int. J. Radiat. Oncol. Biol. Phys. 27 (1992) 969
34. Eifel P.J. Vulvar carcinoma: radiotherapy or surgery for the lymphatics?. Front. Radiat. Ther. Oncol. 28 (1994) 218
35. Hallak S., Ladi L., and Sorbe B. Prophylactic inguinal-femoral irradiation as an alternative to primary lymphadenectomy in treatment of vulvar carcinoma. Int. J. Oncol. 31 (2007) 1077-1085
36. Leiserowitz G.S., Russell A.H., Kinney W.K., Smith L.H., Taylor M.H., and Scudder S.A. Prophylactic chemoradiation of inguinofemoral lymph nodes in patients with locally extensive vulvar cancer. Gynecol. Oncol. 66 (1997) 509-514
37. Hopkins M.P., and Morley G.W. Pelvic exenteration for the treatment of vulvar cancer. Cancer 70 (1992) 2835-2838
38. Boronow R.C. Therapeutic alternative to primary exenteration for advanced vulvovaginal cancer. Gynecol. Oncol. 1 (1973) 233-255
39. Boronow R.C. Combined therapy as an alternative to exenteration for locally advanced vulvovaginal cancer: rationale and results. Cancer 49 (1982) 1085-1091
40. Whitney C.W., Sause W., Bundy B.N., Malfetano J.H., Hannigan E.V., Fowler W.C., Clarke-Pearson D.L., and Liao S.Y. A randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stages IIB-IVA carcinoma of the cervix with negative para-aortic lymph nodes: a Gynecologic Oncology Group and Southwest Oncology Group study. J. Clin. Oncol. 17 (1999) 1339-1348
41. Morris M., Eifel P.J., Lu J., Grigsby P.W., Levenback C., Stevens R.E., Rotman M., Gershenson D.M., and Mutch D.G. Pelvic radiation with concurrent chemotherapy versus pelvic and para-aortic radiation for high-risk cervical cancer: a randomized Radiation Therapy Oncology Group clinical trial. N. Engl. J. Med. 340 (1999) 1137-1143
42. Rose P.G., Bundy B.N., Watkins E.B., Thigpen J.T., Deppe G., Maiman M.A., Clarke-Pearson D.L., and Insalaco S. Concurrent cisplatin based radiotherapy and chemotherapy for locally-advanced cervical cancer. N. Engl. J. Med. 340 (1999) 1144-1153
43. Peters III W.A., Liu P.Y., Barrett R.J., Stock R.J., Monk B.J., Berek J.F., Souhami L., Grigsby P., Gordon W., and Alberts D.S. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18 (2000) 1606-1613
44. Keys H.M., Bundy B.N., Stehman F.B., Okagaki T., Gallup D.G., Burnett A.F., Rotman M.Z., and Fowler W.C. Radiation therapy with and without extrafascial hysterectomy for bulky stage IB cervical carcinoma: a randomized trial of the Gynecologic Oncology Group. Gynecol. Oncol. 89 (2003) 343-353
45. Clinical Announcement. National Cancer Institute. Concurrent chemoradiation for cervical cancer. U. S. Department of Health and Human Services, Public Health Service, National Institutes of Health. February, 1999
46. Kuzuya K. Chemoradiotherapy for uterine cancer: current status and perspectives. Int. J. Clin. Oncol. 9 (2004) 458-470
47. Nigro N.D., Vaitkevicius V.K., and Considine B. Combined therapy for cancer of the anal canal: a preliminary report. Dis. Colon Rectum. 17 (1974) 354-356
48. Cummings B., Keane T., Thomas G., Harwood A., and Rider W. Results and toxicity of the treatment of anal canal carcinoma by radiation therapy or radiation therapy and chemotherapy. Cancer 54 (1984) 2062-2068
49. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J. Clin. Oncol. 14 (1996) 2527-2539
50. Rich T.A., Ajani J.A., Morrison W.H., Ota D., and Levin B. Chemoradiation therapy for anal cancer: radiation plus continuous infusion of 5-fluorouracil with or without cisplatin. Radiother. Oncol. 27 (1993) 209-215
51. Ajani J.A., Winter K.A., Gunderson L.L., et al. Fluorouracil, mitomycin, and radiotherapy versus fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA 299 (2008) 1914-1921
52. Cummings B.J. Current management of anal canal cancer. Semin. Oncol. 32 6 Suppl 9 (2005) S123-S128
53. Iversen T. Irradiation and bleomycin in the treatment of inoperable vulval carcinoma. Acta Obstet. Gynecol. Scand. 61 (1982) 195-197
54. Scheistroen M., and Trope C. Combined bleomycin and irradiation in preoperative treatment of advanced squamous cell carcinoma of the vulva. Acta Oncol. 32 (1992) 657
55. Levin W., Goldberg G., Altaras M., Bloch B., and Shelton M.G. The use of concomitant chemotherapy and radiotherapy prior to surgery in advanced stage carcinoma of the vulva. Gynecol. Oncol. 25 (1986) 20-25
56. Evans L.S., Kersh C.R., Constable W.C., and Taylor P.T. Concomitant 5-fluorouracil, mitomycin C, and radiotherapy for advanced gynecologic malignancies. Int. J. Radiat. Oncol. Biol. Phys. 15 (1988) 901
57. Thomas G., Dembo A., DePetrillo A., et al. Concurrent radiation and chemotherapy in vulvar carcinoma. Gynecol. Oncol. 34 (1989) 263-267
58. Whalen S.A., Slater J.D., Wagner R.J., et al. Concurrent radiation therapy and chemotherapy in the treatment of primary squamous cell cancer of the vulva. Cancer 75 (1995) 2289
59. Landoni F., Maneo A., Zanetta G., et al. Concurrent preoperative chemotherapy with 5-fluorouracil and mitomycin C and radiotherapy (FUMIR) followed by limited surgery in locally advanced and recurrent vulvar carcinoma. Gynecol. Oncol. 61 (1996) 321
60. Lupi G., Raspagliesi F., Zucali R., et al. Combined preoperative chemoradiotherapy followed by radical surgery in locally advanced vulvar carcinoma: a pilot study. Cancer 77 (1996) 1472
61. Akl A., Akl M., Boike G., et al. Preliminary results of chemoradiation as a primary treatment for vulvar carcinoma. Int. J. Radiat. Biol. Phys. 48 (2000) 415
62. Mulayim N., Silver D.F., Schwartz P.E., and Higgins S. Chemoradiation with 5-fluorouracial and mitomycin C in the treatment of vulvar squamous cell carcinoma. Gynecol. Oncol. 93 (2004) 659-666
63. Koh W.J., Wallace H.J., Greer B.E., et al. Combined radiotherapy in the management of local-regionally advanced vulvar cancer. Int. J. Radiat. Oncol. Biol. Phys. 26 (1993) 809-816
64. Han S.C., Kim D.H., Higgins S.A., Carcangiu M.L., and Kacinski B.M. Chemoradiation as primary or adjuvant treatment for locally advanced carcinoma of the vulva. Int. J. Radiat. Oncol. Biol. Phys. 47 (2000) 1235
65. Berek J.S., Heaps J.M., Fu Y.S., et al. Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva. Gynecol. Oncol. 42 (1991) 197
66. Russell A.H., Mesic J.B., Scudder S.A., et al. Synchronous radiation and cytotoxic chemotherapy for locally advanced or recurrent squamous cancer of the vulva. Gynecol. Oncol. 47 (1992) 14
67. Eifel P.J., Morris M., Burke T.W., Levenback C., and Gershenson D.M. Preoperative continuous infusion cisplatinum and 5-fluorouracil with radiation for locally advanced or recurrent carcinoma of the vulva. Gynecol. Oncol. 59 (1995) 51
68. Cunningham M.J., Goyer R.P., Gibbons S.K., et al. Primary radiation, cisplatin, and 5-fluorouracil for advanced squamous carcinoma of the vulva. Gynecol. Oncol. 66 (1997) 258
69. Gerszten K., Selvaraj R.N., Kelley J., and Faul C. Preoperative chemoradiation for locally advanced carcinoma of the vulva. Gynecol. Oncol. 99 (2005) 640-644
70. Moore D.H., Thomas G.M., Montana G.S., Saxer A., Gallup D.G., and Olt G. Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group. Int. J. Radiat. Oncol. Biol. Phys. 42 (1998) 79-85
71. Montana G.S., Thomas G.M., Moore D.H., Saxer A., Mangan C.E., Lentz S.S., and Averette H.E. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a Gynecologic Oncology Group study. Int. J. Radiat. Oncol. Biol. Phys. 48 (2000) 1007-1013
72. Micha J.P., Goldstein B.H., Rettenmaier M.A., Caillouette J.T., Fee M.J., and Brown J.V. Pelvic radiation necrosis and osteomyelitis following chemoradiation for advanced stage vulvar and cervical carcinoma. Gynecol. Oncol. 101 (2006) 349-352
73. Hoffman K.E., Horowitz N.S., and Russell A.H. Healing of vulvo-vaginal radionecrosis following revascularization. Gynecol. Oncol. 106 (2007) 262-264
74. Van Doorn H.C., Ansink A., Verhaar-Langereis M., and Stalpers L. Neoadjuvant chemoradiation for advanced primary vulvar cancer. Cochrane Database Syst. Rev. 3 (2006) CD003752
75. Jhingran A. Potential advantages of intensity-modulated radiation therapy in gynecologic malignancies. Semin. Radiat. Oncol. 16 (2006) 144-151
76. Beriwal S., Heron D.E., Kim H., et al. Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: a comparative dosimetric study with early clinical outcome. Int. J. Radiat. Oncol. Biol. Phys. 64 (2006) 1395-1400
77. Beriwal S., Coon D., Heron D.E., et al. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma. Gynecol. Oncol. 109 (2008) 291-295